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ABSTRACT
HIV’s effects on episodic memory have not been compared systematically between
male and female substance-dependent individuals. We administered the Brief
Visuospatial Memory Test–Revised (BVMT–R) to 280 substance-dependent HIV+ and
HIV– men and women. Groups were comparable on demographic, substance use, and
comorbid characteristics. There were no significant main effects of sex or HIV serostatus
on BVMT–R performance, but HIV+ women performed significantly more poorly on
delayed recall. This effect was most prominent among cocaine-dependent HIV+
women. Our findings are consistent with recent speculation that memory impairment
may be more common among HIV+ women, particularly those with a history of cocaine
dependence.
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“Episodic memory” refers to a neurocognitive sys-
tem that enables human beings to remember
experiences such as details of a conversation or a
list of words read aloud (Tulving, 1972). Episodic
memory is frequently impaired among individuals
living with HIV/AIDS (Murji et al., 2003), with
estimates ranging from 40–60% of HIV+ indivi-
duals (Carey et al., 2004; Heaton et al., 2011), and
such impairment significantly predicts rates of
employment and critically important daily func-
tions such as adherence with antiretroviral therapy
regimens (Heaton et al., 1994, 2004; Obermeit,
Morgan, Casaletto, Grant, & Woods, 2015;
Woods et al., 2008).
Episodic memory is critically dependent on the
integrity of hippocampal and prefrontal cortical
circuitry (Dickerson & Eichenbaum, 2010), and
neuroimaging studies of HIV and episodic mem-
ory have successfully detected alterations in pre-
frontal and hippocampal activity compared with
HIV– control groups (Castelo, Sherman,
Courtney, Melrose, & Stern, 2006; Maki et al.,
2009; Melrose, Tinaz, Castelo, Courtney, & Stern,
2008). Early studies of episodic memory1 impair-
ment among HIV+ individuals often emphasized
its clinical similarities with the pattern of deficits
commonly observed among patients with
Parkinson disease and other basal ganglia disorders
(Martin, 1994; Sadek et al., 2004; Woods, Moore,
Weber, & Grant, 2009), such as impaired free
recall with relatively intact recognition, suggesting
deficient retrieval in the context of relatively pre-
served encoding. More recently, HIV-associated
memory impairment has been attributed primarily
to breakdown of executive, or “strategic,” processes
that facilitate recall, such as clustering words by
semantic categories (Gongvatana, Woods, Taylor,
Vigil, & Grant, 2007; Woods et al., 2005); or
employing contextual (source) information
(Morgan et al., 2012; Morgan et al., 2009), reflect-
ing dysfunction of frontostriatal systems (Castelo
et al., 2006; Meyer et al., 2014). Although the
CONTACT Eileen M. Martin eileen_martin@rush.edu Department of Psychiatry, Rush University Medical Center, 1645 W. Jackson Blvd.,
Suite 600, Chicago, IL 60612, USA
1Although prospective memory is considered a type of episodic memory, it was not investigated in the current
study, and throughout this article, the term “episodic memory” refers specifically to recall of previous informa-
tion (“retrospective”).
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majority of studies of HIV’s effects on episodic
memory have focused on the acquisition and
retention of verbal material, similar deficits in
strategic organizational processing of visual infor-
mation have also been reported (Morgan et al.,
2009).
Studies of HIV effects on episodic memory have
typically been conducted with all- or primarily
male participant groups. However, recent findings
in the literature suggest that the profile of HIV-
associated neurocognitive impairment may differ
for men and women (e.g., Maki & Martin-
Thormeyer, 2009; Maki et al., 2014). A recent
report from the Women’s Interagency HIV Study
(WIHS), the largest study (N = 1521) of HIV
disease progression in women to date (Maki
et al., 2014) demonstrated that HIV+ women per-
formed significantly more poorly than HIV–
women on measures of verbal episodic memory,
but not on measures of processing speed (Symbol
Digit Modalities Test) or executive functioning
(Stroop, Trail Making Test B), which are typically
impaired among HIV+ men (Woods et al., 2009).
Maki et al. (2014) speculated that verbal memory
deficits might be more prominent among HIV+
women than among men, but limited evidence is
available to address this question, since few studies
have compared neurocognitive performance of
HIV+ men and women directly (Behrman-Lay
et al., 2016; Hestad et al., 2012; Robertson et al.,
2005; Royal et al., 2004) with inconsistent results.
Studies that have targeted neurocognitive per-
formance specifically among substance-dependent
HIV+ men and women (Failde-Barrido, Alvarez, &
Simón-López, 2008; Martin, Gonzalez, Vassileva, &
Maki, 2011, 2016; Wisniewski et al., 2005) have
reported more consistent evidence of sex differ-
ences in neurocognitive performance, although
the cognitive domains affected have varied, sug-
gesting that sex differences in HIV-associated neu-
rocognitive impairment could be more prominent
among individuals with substance use disorders
(SUDs).
Drugs of abuse increase HIV’s neurotoxic
effects through multiple mechanisms, including
accelerated viral replication (Liang et al., 2008),
increased immunosuppression (Dhillon et al.,
2007), and interaction with viral proteins such
as tat and gp120 to facilitate breakdown of the
blood brain barrier and release of TNF-α and
other neurotoxic cytokines. (Flora et al., 2003;
Hauser et al., 2006; Hu, Sheng, Lokensgard, &
Peterson, 2005; Theodore, Cass, & Maragos,
2006). Recent literature has reported a range of
independent and combined effects of a positive
HIV serostatus and substances of abuse on neu-
rocognition and neurobehavioral function (e.g.,
Rippeth et al., 2004; Schulte et al., 2005), and
these findings may inform development of new
cognitive and behavioral interventions for sub-
stance use or HIV prevention.
In the current study, we administered the Brief
Visuospatial Memory Test–Revised (BVMT–R;
Benedict, 1997), a standardized measure of visual
episodic memory routinely employed in studies
of HIV and neurocognition (e.g., Heaton et al.,
2011; Woods et al., 2009), to a sample of 280
HIV+ and HIV– male and female substance-
dependent individuals (SDIs) verified abstinent
at testing. We compared participant groups’ per-
formance on indices of immediate and delayed
recall, and on recognition memory. Goals of the
study were twofold: to determine whether HIV+
SDIs show poorer episodic visual memory per-
formance than HIV– SDIs with comparable
demographic, substance use and comorbid char-
acteristics; and to investigate potential unique
and interactive effects of sex and HIV serostatus
on visual memory. Thus our primary study
hypotheses predicted that: (a) mean BVMT–R
Total (immediate) Recall, Delayed Recall, and
Recognition Memory scores would be signifi-
cantly lower among the HIV+ than among
HIV– SDIs; and (b) mean Total and Delayed
Recall scores and Recognition Discrimination
indices would be significantly lower among the
HIV+ women than among HIV+ men.
Based on recent reports from the WIHS that
crack cocaine use among HIV+ women
increases short-term morbidity and risk of neu-
rocognitive impairment (Cook et al., 2008;
Meyer et al., 2013), we also tested exploratory
hypotheses that: (a) BVMT–R immediate and
delayed recall and recognition scores would be
lowest among HIV+ women than in the other
participant groups, and (b) this deficit would be
most prominent among HIV+ women with a
history of crack cocaine use. Finally, we
explored potential sex and HIV serostatus
effects on item-associative and source memory
components of BVMT–R Delayed Recall
(Morgan et al., 2012) that index the functional
integrity of hippocampal and prefrontal-striatal
systems, respectively.
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Method
Participants
Participants included 128 HIV+ and 152 enzyme
immunoassay (EIA)-verified HIV– substance-
dependent individuals (SDIs) enrolled in a larger
study of sex and HIV serostatus effects on neuro-
cognition among substance users. Participants
were recruited from infectious disease clinics at
Rush University Medical Center (RUMC),
University of Illinois at Chicago (UIC), and Ruth
M. Rothstein CORE Center at Stroger (formerly
Cook County) Hospital, from community agen-
cies, and by word of mouth. All participants were
18–60 years old, were fluent in English, had eight
or more years of education, and met DSM–IV
(Diagnostic and Statistical Manual of Mental
Disorders–Fourth Edition; American Psychiatric
Association, 1994) criteria for abuse or dependence
on at least one substance (primarily crack cocaine
or heroin—see Table 1) other than caffeine or
nicotine. The majority of participants met DSM–
IV criteria for SUDs in “early” (had not met full
criteria for at least 30 days but less than 1 year) or
“sustained” (had not met full criteria for more than
1 year) remission (see Figure 1).
The HIV+ participants were required to be ambu-
latory and capable of completing two 90–120-min
testing visits without excess fatigue. Study partici-
pants were primarily urban-dwelling African-
Americans, reflecting the demographic characteristics
of HIV+ and HIV– SDIs receiving medical and sub-
stance use care through UIC, CORE, Rush, and local
substance use treatment programs. Exclusion criteria
included AIDS-defining or other central nervous sys-
tem disorders such as stroke or brain tumor, closed
head injury with loss of consciousness greater than
30 min, open head injury of any kind, schizophrenia,
or current neuroleptic medications. Participants were
informed at recruitment that breathalyzer and rapid
Table 1. Demographic, substance abuse, and comorbidity characteristics for all participants.
HIV– men HIV+ men HIV– women HIV+ women Statistic+ p Group comparisons
Demographics
n 75 76 77 52
Age (years) 51.0 (5.3) 48.4 (7.4) 48.7 (8.6) 46.0 (8.3) 4.51 .004 M– > W+
Years of education 12.5 (1.4) 12.8 (1.8) 12.4 (1.9) 11.3 (2.0) 8.00 .001 M–, M+,W– > W+
WTAR-estimated FSIQ 90.5 (11.3) 90.5 (11.5) 89.1 (10.6) 84.8 (8.2) 3.46 .017 M–, M+ > W+
% African American 95 87 82 90 16.89 .05 M– > W–
Substance use
Mean ASI scores
Alcohol .07 (.16) .06 (.11) .03 (.11) .01 (.03) 2.96 .04 M– > W+
Drug .03 (.08) .03 (.06) .04 (.07) .02 (.06) 0.38 .78
Mean KMSK scores
Alcohol 10.9 (2.9) 10.9 (2.7) 10.2 (3.3) 10.6 (3.2) 0.85 .47
Cocaine 12.2 (5.2) 12.9 (4.8) 12.4 (5.5) 13.5 (4.6) 0.87 .46
Heroin/opiates 5.5 (5.4) 3.5 (4.7) 7.0 (5.2) 5.8 (5.4) 6.32 <.001 W– > M+
% DSM–IV dependence
Alcohol 55 64 57 67 2.94 .40
Cannabis 36 43 32 27 4.08 .25
Cocaine 72 70 70 83 3.24 .36
Opioid 35 22 49 36 12.18 .007 W– > M+
% Injection drug user 16 22 17 23 1.75 .63
% Overdose 17 15 22 21 1.78 .62
% HCV+ 12 26 12 15 6.67 .08
Comorbidities
% MDD 20 29 38 39 7.37 .06
PCL–C 36.3 (13.3) 34.9 (13.4) 40.9 (15.3) 39.7 (14.4) 2.89 .04*
WURS 28.1 (17.9) 30.2 (21.7) 30.4 (20.4) 36.1 (23.8) 1.56 .20
SRPS 48.6 (9.8) 50.0 (9.8) 50.0 (10.4) 49.3 (9.5) 0.32 .81
HIV disease
Mean CPE scores 7.7 (2.4) 7.1 (2.5) 1.41 .16
Md current CD4 (cells µL–1) 467 540 1494 .12
Md nadir CD4 (cells µL–1) 186 300 1035 .01 W+ > M+
% Undetectable VL 71 77 1.75 .19
% cART 96 94 .26 .61
Note. WTAR = Wechsler Test of Adult Reading; FSIQ = Full Scale Intelligence Quotient; ASI = Addiction Severity Index; KMSK = Kreek–McHugh–
Schluger–Kellogg Scale; DSM–IV = Diagnostic and Statistical Manual of Mental Disorders–Fourth Edition; HCV = hepatitis C virus; MDD = major
depressive disorder; PCL–C = PTSD (posttraumatic stress disorder) Checklist—Civilian Version; WURS = Wender Utah Rating Scale;
SRPS = Levenson Self-Report Psychopathy Scale; CPE = CNS (central nervous system) Penetration Effectiveness; VL = viral load;
cART = combination antiretroviral therapy; M– = HIV– men; M+ = HIV+ men; W– = HIV– women; W+ = HIV+ women. Mean values, with
standard deviations in parentheses. +Chi-square tests were used for categorical data (%) and Mann Whitney statistic with Z correction for non-
normally distributed data (Md). All other analyses used one-way analysis of variance (ANOVA).
*PCL–C (omnibus F) p = .04; W– vs. HIV+, p = .065 by Tukey honestly significant difference (HSD).
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urine toxicology screens would be administered at
each study visit; the study visit would be terminated
without payment if either test was positive. The study
was approved by institutional review boards at Rush,
the CORE Center, and UIC.
Procedure
Tests administered were part of a larger study pro-
tocol encompassing two 120–150-min visits at the
Department of Psychiatry at RUMC. Testing was
conducted by bachelor’s level research assistants
under the supervision of a board-certified clinical
neuropsychologist (E.M.M.). Written informed con-
sent was obtained on arrival for the first study visit.
On both study visits, participants underwent a rapid
urine toxicology screen that tested for 10 illicit and
prescription drugs, including opioids, cocaine, can-
nabis, benzodiazepines, and amphetamine.
Participants also completed a breathalyzer test to
ensure abstinence from alcohol at the time of testing.
If a potential participant tested positive for alcohol
or other drugs, the visit was terminated, the partici-
pant received no payment, and the visit was
rescheduled.2 All participants were informed of
these contingencies prior to the testing visit. They
received $75 cash compensation for their time and
transportation costs at the completion of each study
visit. Participants also received a $10 bonus for pas-
sing both breathalyzer and urine drug screen tests
and arriving at all appointments on time.
Measures
Clinical and personality measures
Each participant was administered the Wechsler
Test of Adult Reading (WTAR; Wechsler, 2001)
to estimate premorbid verbal IQ. Participants
also completed a series of computerized and
paper-and-pencil measures of potentially con-
founding conditions comorbid with substance
use disorders. These included symptoms of
mood disorder (Affective Disorder Module of
the Structured Clinical Interview for DSM–IV,
SCID; First, Spitzer, Gibbon, & Williams, 1995);
posttraumatic stress disorder (PTSD Checklist–
Civilian Version, PCL–C; Blake et al., 1995);
attention deficit disorder (Wender Utah Rating
Scale, WURS; Stein et al., 1995); and antisoci-
ality (Levenson Self-Report Psychopathy Scale,
SRPS; Levenson, Kiehl, & Fitzpatrick, 1995).
Finally, all HIV+ participants completed the
central nervous system (CNS) Penetrance
Effectiveness (CPE) scale (e.g., Letendre et al.,
2008; Smurzynski et al., 2011), which ranks
each antiretroviral compound in the partici-
pant’s current regimen according to its capacity
to cross the blood–brain barrier; the total CPE
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Figure 1. Percentage of all participants with Diagnostic
and Statistical Manual of Mental Disorders–Fourth Edition
(DSM–IV) diagnoses of “current,” “early remission,” and
“sustained remission” for dependence on alcohol, canna-
bis, opioid, and cocaine.
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Figure 2. Mean Brief Visuospatial Memory Test–Revised
(BVMT–R) delayed recall T-scores for cocaine-dependent
male and female participants with and without a positive
HIV serostatus. **p < .01, HIV+ women < HIV– women,
HIV+ men, HIV– men by one-way analysis of variance
(ANOVA) with planned contrast.
2Participants who tested positive for cannabis were not excluded if testing was negative for all other substances.
The presence of THC metabolites in the urine did not necessarily indicate cannabis use within 1–2 days prior to
testing due to its much longer half-life.
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score is obtained by summing the individual
ranks.
Substance use
Participants were administered Substance Abuse
and Affective Disorder modules of the NetSCID
(TeleSage, http://www.telesage.com/products/nets
cid.html), a computer-assisted version of the
Structured Clinical Interview for DSM–IV (SCID;
First et al., 1997) to derive DSM–IV substance use
diagnoses for each participant. Additionally, parti-
cipants completed the Addictions Severity Index
(ASI; McLellan, Luborsky, Woody, & O’Brien,
1980) and the Kreek–McHugh–Schluger–Kellogg
scale (KMSK; Kellogg et al., 2003). The KMSK is
used to derive indices of peak lifetime severity of
alcohol, cocaine, and opioid use; participants are
queried about the amount of money spent, fre-
quency of use, and duration of the period of their
heaviest use.
Visual memory
All participants were administered the Brief
Visuospatial Memory Test–Revised (BVMT–R;
Benedict, 1997), a standardized clinical neuropsy-
chological test of visual episodic memory routinely
employed in neurocognitive studies of HIV (e.g.,
Heaton et al., 2011). The BVMT–R consists of
three 10-s presentations of six geometric figures
in a 2 × 3 array. After each presentation, the dis-
play is removed from view, and participants are
asked to draw as many figures as they can recall in
their correct positions on the page. Participants
receive one point for each design recalled correctly
and one point for each design’s correct spatial
location. The maximum raw score for the three
initial learning trials is 36. Free recall is tested
again following a 25-min delay. A recognition
trial is then administered, in which the respondent
is asked to identify which of 12 figures—six targets
and six foils—were included among the original set
of six designs.
The primary dependent variables used for this
study were total (immediate) recall (the sum of
points earned across the three initial learning trials)
and delayed recall (the total number of points
earned when recall is tested 25 min later, using
norm-referenced T-scores (Benedict, 1997); and
Recognition Discrimination Index raw scores (num-
ber of recognition hits minus false alarms; T-scores
are not provided for this index).
Additionally, BVMT–R Delayed Recall raw
scores were partitioned into separate “Item” and
“Location” subscores, following methods intro-
duced by Troyer and colleagues (Troyer et al.,
2008) and previously employed by Morgan and
colleagues to study BVMT–R performance among
methamphetamine users (Morgan et al., 2012).
Item (associative) and Location (source memory)
scores provide indices of dissociable memory com-
ponents critically dependent on integrity of hippo-
campal and frontostriatal systems, respectively
(Kirwan & Stark, 2004). Each correctly recalled
figure, regardless of its spatial position on the
response sheet, received 1 point on the Item sub-
scale. Any figure properly positioned in one of the
six spatial locations on the response sheet received
1 point on the Location subscale. Both subscales
yielded maximum scores of 6. We then trans-
formed the raw Item and Location scores to T-
scores using means and standard deviations for the
HIV– group.
Overview of statistical analyses
Demographic, substance use, and comorbidity data
for the four groups were compared using one-way
analyses of variance (ANOVA) for parametric
data. Tukey honestly significant difference (Tukey
HSD) tests were used for post hoc testing. Mann–
Whitney U tests with the z approximation were
used for non-normally distributed data, and chi-
square tests were used for categorical data. An
alpha threshold of .05 was employed for all group
comparisons. BVMT–R raw scores for both total
and delayed recall were converted to age-adjusted
T-scores using standardized norms (Benedict,
1997). Tests of the primary hypotheses employed
Sex × HIV Serostatus factorial analyses of covar-
iance (ANCOVAs; selection of covariates is
described below).
Results
Tests of potentially confounding variables
Prior to tests of the primary hypotheses, we com-
pared demographic, substance use, and comorbid
variables among the four groups to determine
whether the groups differed significantly on any
potentially confounding characteristics, or if HIV
disease severity was different for men and women.
Table 1 provides detailed results of these group
comparisons. Groups were generally comparable
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overall on demographic variables (see Table 1 for
omnibus F statistics); however, mean years of edu-
cation were significantly lower for the HIV+
women than for the other three groups, p < .001
for all tests. HIV– men were older (p = .002) and
had higher mean estimated Full-Scale Intelligence
Quotient (FSIQ) scores than HIV+ women
(p = .02). Mean estimated FSIQ scores were also
lower for HIV+ women than for HIV+ men
(p = .03). A higher percentage of the HIV– men
than HIV– women were African American, χ2
(3) = 16.9, p = .05.
The four participant groups were also generally
comparable on comorbid characteristics, with the
exception of a marginally significant trend (p = .06)
toward higher PCL–C scores for the HIV– women
than for the HIV+ men. Mean ASI3–Alcohol scores
were significantly higher among HIV– men than
among HIV+ women, p = .04. There were significant
group differences in the prevalence of DSM–IV diag-
noses of opioid dependence, χ2(3) = 12.18, p = .007:
HIV– women had the highest rate of opioid depen-
dence (49%), whereas HIV+ men had the lowest rate
of the four groups (22%). Additionally, HIV–women
obtained higher mean KMSK–Heroin scores than
HIV+ men, p < .001.
HIV disease characteristics at testing were gener-
ally similar between men and women (see Table 1).
However, median nadir CD4 count was significantly
lower, Mann–WhitneyU = 1034.5, z = −2.55, p = .01,
and lifetime prevalence of immunologic AIDS was
significantly more common among men than among
women, χ2(1) = 7.88, p = .005. Essentially all HIV+
participants (96% of the HIV+ men and 94% of the
HIV+ women) were prescribed combination antire-
troviral therapy (cART).
Brief Visuospatial Memory Test–Revised
Mean Total and Delayed Recall T-scores and mean
Recognition Discrimination Index (RDI) raw4
scores were positively correlated with WTAR-
estimated Verbal IQ scores (r = .33, p < .005;
r = .34, p < .001; r = .13, p < .05, respectively),
but not with age (|r|≤ .09, p ≥ .14 for all tests),
ASI–Alcohol scores (|r|≤ .10, p ≥ .18 for all tests),
or KMSK–Heroin scores (|r|≤ .14, p ≥ .18 for all
tests). Primary analyses of BVMT–R data were
therefore conducted using Sex × HIV Serostatus
ANCOVA, controlling for WTAR-estimated IQ
scores.5
Hypothesis 1 predicted that HIV+ SDIs would
perform significantly more poorly on mean
BVMT–R Total (immediate) and Delayed Recall
T-scores and RDI raw scores than HIV– SDIs.
There were no significant main effects of HIV
serostatus for mean Total Recall T-scores, F(1,
265) = 1.72, p = .19; Delayed Recall T-scores, F(1,
265) = 1.50, p = .22; or mean RDI scores, F(1,
265) = 0.51, p = .48.
Hypothesis 2 predicted that HIV+ women
would show poorer visual episodic memory than
HIV+ men. Analyses of Delayed Recall T-scores
revealed a significant Sex × HIV Serostatus inter-
action, F(1, 265) = 4.56, p = .03, η2p = .02. Analysis
of simple main effects revealed that mean Delayed
Recall T-scores were significantly lower for the
HIV+ women than for HIV– women, p = .03,
but not for HIV+ women than for HIV+ men,
p = .14. The Sex × HIV Serostatus interaction did
not reach statistical significance for mean Total
Recall T-scores, F(1, 265) = 2.21, p = .14; or for
mean Recognition Discrimination Index scores, F
(1, 265) = 0.32, p = .57.
Exploratory Hypothesis 1 predicted that mean
Total and Delayed Recall T-scores and mean RDI
raw scores would be lowest for the HIV+ women
compared with the other three participant groups.
One-way ANOVAs with planned contrasts (1 1
1–3) revealed that the HIV+ women showed a
nonsignificant trend toward lower mean Total
Recall T-scores than the other three groups, t
(276) = 1.81, p = .07; while mean Delayed Recall
T-scores were significantly lower for the HIV+
3ASI data were not available for approximately 91 participants; this measure was added to the protocol after data
collection was initiated, and (unlike the BVMT–R) was administered during the second testing visit. Thus,
interpretation of this finding is necessarily tentative.
4Published norm-referenced T-scores were available for Total and Delayed Recall, but not for the Recognition
Discrimination Index. By convention we computed RDI by subtracting the total false positives from the total
recognition hits.
5Years of education were significantly correlated with BVMT–R Total and Delayed Recall and RDI scores (r = .26,
27, and .19, respectively, p < .01). However, forward linear regression analyses of BVMT–R scores with WTAR and
Education as predictors showed evidence of collinearity (eigenvalue = .007). Thus analyses of BVMT–R scores
employed WTAR scores but not education as covariates.
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women than for the other groups, t(276) = 2.58,
p = .01; there were no significant group differences
in mean RDI scores between HIV+ women and the
other three groups, t(276) = 0.84, p = .40.
Exploratory Hypothesis 2 predicted that mean
Total and Delayed Recall T-scores and mean RDI
scores would be lowest among cocaine-dependent
HIV+ women compared with cocaine-dependent
HIV+ men, HIV– women, and HIV– men. To test
this hypothesis, we repeated the one-way ANOVAs
of mean Total Recall and Delayed Recall T-scores
and mean raw RDI scores with cocaine-dependent
participants only (n = 204). Planned contrasts (1 1
1–3) revealed that cocaine-dependent HIV+
women obtained significantly lower mean Total
Recall, t(200) = 2.15, p = .03, and Delayed Recall
T-scores, t(200) = 2.99, p = .003, than the other
groups, but mean RDI scores for cocaine-depen-
dent HIV+ women did not differ significantly
compared with those of the other three cocaine-
dependent groups, t < 1. Figure 2 shows mean
Delayed Recall T-scores for the four groups of
cocaine-dependent participants.
Breakout analyses of cognitive components of
BVMT–R Delayed Recall
Analyses of mean Item and Location T-scores were
conducted in the same order as the analyses of
BVMT–R Total, Delayed, and Recognition scores
(see above). Hypothesis 1: There were no signifi-
cant main effects of HIV serostatus for either the
mean Item or Location Delayed Recall T-scores,
F < 1 for both tests. Hypothesis 2: Analyses of
mean Item Delayed Recall T-scores revealed a sig-
nificant Sex × HIV Serostatus interaction, F(1,
262) = 4.56, p = .03, η2p= .02. Tests of simple
main effects revealed that the HIV+ women per-
formed significantly more poorly than HIV–
women (p = .04), but not than HIV+ men
(p = .24). The Sex × HIV Serostatus interaction
for mean Location Delay T-scores was nonsignifi-
cant, F(1, 262) = 1.76, p = .18). Exploratory
Hypothesis 1: One-way ANOVA of mean Item
Delay T-scores with planned contrast (1 1 1–3)
revealed that mean scores for HIV+ women were
significantly lower than those of the other groups, t
(269) = 2.01, p = .05.
Exploratory Hypothesis 2: Among the cocaine-
dependent participants, one-way ANOVA of mean
Item Delayed Recall T-scores using planned con-
trast (1 1 1–3) revealed that mean scores for HIV+
women were significantly lower than those of the
other groups, t(193) = 2.10, p = .04.
Additional analyses
We performed a series of correlations between
BVMT–R Total and Delayed Recall T-scores with
HIV disease, substance use, and other demo-
graphic characteristics. There were no significant
correlations between the HIV+ participants’ cur-
rent or nadir CD4 counts or HIV RNA levels with
mean BVMT–R Total or Delayed Recall T-scores
or with RDI scores, |r|≤ .14, p > .11 for all tests.
Mean BVMT–R Total and Delayed Recall T-scores
and raw Recognition Discrimination Index scores
were significantly correlated with CNS Penetration
Effectiveness Scale Scores (Total Recall: r = .24,
p = .01; Delayed Recall: r = .24, p = .03; RDI:
r = .19, p = .04). We repeated the analyses of
mean BVMT–R Total and Delayed Recall T-scores
and RDI scores between the HIV+ men and
women, controlling for WTAR IQ estimates and
CPE scores, but results were unchanged.
Among the comorbid variables, mean Self-
Report Psychopathy Scale (SRPS) scores correlated
significantly and inversely with mean Total and
Delay Recall T-scores, r = −.24 and −.26,
p < .001, respectively, but not with RDI scores,
r = –.05, p = .43. We repeated the Sex × HIV
Serostatus ANCOVAs comparing Immediate and
Delayed Recall T-scores and Recognition while
controlling for SRPS and WTAR IQ scores, and
results were unchanged. We also repeated the ana-
lyses of the mean BVMT–R Total and Delayed T-
scores of HIV+ men and women controlling for
mean SRPS, WTAR IQ, and CPE scores, and
results were unchanged. No significant correlations
were observed between BVMT–R Total and
Delayed Recall T-scores or RDI raw scores with
any substance use variable, p > .10 for all tests.
Discussion
This study compared visual episodic memory per-
formance among 280 HIV+ and HIV– men and
women with a history of substance dependence but
verified abstinent at testing. All participants com-
pleted the Brief Visuospatial Memory Test–Revised
and a series of measures of substance abuse and
comorbid psychiatric disorders and personality
traits with potentially confounding effects on
memory performance.
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Contrary to prediction, we found no evidence of
generalized visual memory impairment among
HIV+ compared with HIV– SDIs. Rather, we
found consistent evidence of selective impairment
on the BVMT–R delayed recall component among
the HIV+ women. This deficit was most promi-
nent among HIV+ women with a history of
cocaine dependence, and was only detectable on
the cue/associative (item) component of BVMT–R
recall.
The groups were generally comparable on
demographic characteristics, with the exception of
age, education, and estimated premorbid IQ; mean
age was lowest for the HIV+ women and was
uncorrelated with BVMT–R performance, which
argues against attributing the HIV+ women’s
poorer performance to age effects, and we con-
trolled for estimated IQ (but not education, due
to collinearity between education and WTAR IQ
scores) in all subsequent analyses of BVMT–R
data. Participant groups were also generally com-
parable on substance use and comorbid character-
istics. Notably, the HIV– women showed a
significantly higher prevalence of opioid depen-
dence, and severity of peak opioid use, and the
HIV– men reported significantly more alcohol
use in the last 30 days suggesting that the HIV+
women’s poorer delayed recall performance was
not readily explained by nonspecific group differ-
ences in addiction severity. Similarly, HIV+
women’s impaired delayed recall could not be
attributed to sex differences in HIV disease sever-
ity, as nadir CD4 counts were significantly lower
for HIV+ men than for HIV+ women, and there
were no significant associations between BVMT–R
performance and viral load or AIDS-defining CD4
counts.
The HIV+ women’s memory performance was
characterized by impaired free recall with no evi-
dence of rapid forgetting and essentially intact
recognition, consistent with reports from previous
studies of verbal episodic memory performance
among HIV+ individuals (Maki et al., 2015;
Woods et al., 2005). However, our findings could
not address in detail the critically important ques-
tion of whether the HIV+ women’s poor perfor-
mance was characterized primarily by impairment
in “executive” strategies such as semantic cluster-
ing, since these constructs are not captured
adequately by the BVMT–R.6 Studies of verbal
episodic memory performance, which will provide
semantic clustering data, are currently in progress
in our lab.
Our findings suggest that performance on epi-
sodic memory tasks is not identical for HIV+ men
and women: Breakout analyses revealed that HIV+
women were selectively impaired on the “item” but
not the “source” component of mean BVMT–R
Delayed Recall scores. Notably, “item” and
“source” components of episodic memory are con-
sidered indices of the integrity of hippocampal and
frontostriatal circuitry (Morgan et al., 2012),
respectively, raising the question of whether hip-
pocampal involvement might be more common or
severe among HIV+ women than among HIV+
men. HIV+ women show alterations in hippocam-
pal function that correlate with performance on
episodic memory tasks outside of the scanner
(Maki et al., 2009). This hippocampal vulnerability
may be compounded by low estrogen levels, as
estradiol levels are lower in HIV+ women (Karim
et al., 2013; Santoro et al., 2007), particularly
cocaine-dependent HIV+ women (Santoro et al.,
2007), than in HIV– women. Additionally, cortisol
levels are high in recently abstinent cocaine-depen-
dent women (Fox, Hong, Siedlarz, & Sinha, 2008),
and high levels of cortisol are associated with
decreased memory performance, particularly
when estrogen levels are low (Maki et al., 2015).
Inferences from study data are necessarily limited,
since data regarding contraceptive use and men-
strual cycling among our female participants were
not available; however, studies of neurocognitive
performance and fluctuations in sex steroid levels
among HIV+ and HIV– women tested at two
different phases of the menstrual cycle are cur-
rently in progress by our group, and findings
may shed light on potential cognitive and neural
mechanisms of episodic memory impairment
among HIV+ women.
In contrast with our findings, Morgan and col-
leagues (Morgan et al., 2009) reported that HIV+
individuals performed significantly more poorly
than controls on the source but not the item com-
ponent (Morgan et al., 2009) of episodic visual
memory testing. However, our findings do not
necessarily contradict (Morgan et al.’s 2009)
report, as our two studies differ in several critical
6However, Meyer et al. (2013) reported that HIV+ women showed significantly poorer semantic clustering than
HIV– women on a verbal learning task.
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methodological features. HIV+ participants in the
Morgan study were 93% male with a much lower
(53%) prevalence of substance dependence.
Additionally, Morgan et al. employed a modified
spatial Self-Ordered Pointing Task (Petrides &
Milner, 1982) with an array of 12 visual designs
presented over multiple trials. The designs appear
in a new spatial arrangement at the start of each
trial, and the participant must identify a design
that had not been previously selected. In contrast,
the BVMT–R presents an identical spatial array of
six figures over three trials. Morgan et al.’s task
appears considerably more difficult than ours, with
greater demands on working memory processing
and greater engagement of prefrontal-striatal
systems.
Our data are also consistent with reports from
the WIHS that disease-related morbidity is higher,
and risk of neurocognitive impairment is
increased, among HIV+ women who have used
crack cocaine (Cook et al., 2008; Meyer et al.,
2013). By contrast, we found no evidence of selec-
tive visual memory impairment among HIV+
cocaine-dependent men, consistent with previous
reports of varying neurocognitive effects of cocaine
use among primarily male HIV+ participant sam-
ples (Durvasula et al., 2000; Meade, Conn, Skalski,
& Safren, 2011; but cf. Meade, Towe, Skalski, &
Robertson, 2015). More basic and clinical studies
are needed to characterize the increased risk of
neurocognitive impairment among HIV+
cocaine-dependent women in more detail and to
address the question of whether this vulnerability
is HIV-specific; we note that regardless of HIV
serostatus, women are more vulnerable to stimu-
lant addiction than men: The addiction literature
indicates that women escalate their use of stimu-
lants more rapidly, and relapse more readily, than
men (Becker & Hu, 2008; Greenfield, Back,
Lawson, & Brady, 2010).
The current results suggest that HIV’s effects on
episodic memory processing are not modality-spe-
cific and can be detected on tests of visual as well
as verbal memory; this raises the question of
whether HIV disrupts core component mechan-
isms routinely engaged by episodic memory pro-
cessing, similar to earlier findings by our group
that working memory deficits are detectable
among HIV+ SDIs regardless of information type
or task demands (Bartok et al., 1997; Farinpour
et al., 2000; Martin et al., 2001, 2003). However,
preliminary findings from our group on verbal and
spatial episodic memory performance have not
provided strong support for this hypothesis: For
example, both HIV+ men and women showed
impaired delayed recall on a measure of spatial/
navigational learning compared with HIV– groups
(Martin et al., 2015a); in contrast, HIV+ women,
but not HIV+ men, showed impaired immediate
but not delayed recall compared with HIV– groups
on the Hopkins Verbal Learning Test (HVLT;
Martin et al., 2015b). We note that the earlier
working memory studies by our group were con-
ducted with all- or predominantly male study sam-
ples, indicating that our proposal that HIV affects
core working memory mechanisms may be applic-
able only to men; studies of working memory
performance by HIV+ and HIV– male and female
SDIs are currently in progress in our group
(Martin et al., in press).
Notably, successful BVMT–R performance
requires higher order visual processing of objects
and spatial locations engaged by different neural
circuits (Ungerleider, 1995; Ungerleider & Haxby,
1994). Neurons in the parietal association cortex
and superior and middle temporal visual associa-
tion cortex form the “dorsal stream,” coding
objects’ spatial location (Rizzolatti & Matelli,
2003). Neurons in the inferior temporal visual
association cortex form the “ventral stream,”
which processes information regarding the form,
or “what” of objects, allowing for learning and
remembering visual objects (Reddy & Kanwisher,
2006). Importantly, functional magnetic resonance
imaging (fMRI) studies have documented disrup-
tion of fronto-striato-parietal (Schweinsburg et al.,
2012) as well as fronto-striatal networks (Du
Plessis et al., 2014) among HIV+ individuals.
Follow-up studies will be needed to investigate
sex- or HIV-related differences in object and spa-
tial visual processing among substance-dependent
individuals; a positive finding would suggest that
disruption of upstream visual processing could
contribute to poor performance on visual memory
testing.
We found a significant positive correlation
between BVMT–R delayed recall T-scores and CPE
scores, indicating that memory scores were higher
among HIV+ individuals receiving highly CNS-
penetrant antiretroviral therapy (ARV) than among
those on regimens with lower capacity to cross the
blood–brain barrier. The significance of this inci-
dental finding is unclear, however, since the litera-
ture on the relationship between neurocognitive
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performance and ARV CNS penetrance is mixed
(for a recent discussion, see Wilson, Martin-Engel,
Vassileva, Gonzalez, & Martin (2013).
The study has several limitations. These findings
may not be generalizable to HIV+ women who are
non-substance-dependent or dependent on sub-
stances other than cocaine; additionally, the polydrug
use by virtually all our participants poses significant
limits to interpretation of our finding of poorer per-
formance by cocaine-dependent HIV+ women. This
finding is consistent with previous reports from the
WIHS and from our group, but detailed neuroima-
ging, neuroendocrine, and neuropharmacological stu-
dies will be critically important, to test the hypothesis
that HIV+ cocaine-dependent women are at increased
risk for neurocognitive impairment, and to investigate
how known sex differences in the addictive process
might complicate study findings. Finally, although our
study was designed to limit threats to validity posed by
psychiatric and medical disorders comorbid with sub-
stance dependence, these factors cannot be eliminated
entirely, requiring careful monitoring and judicious
application of inclusion/exclusion criteria.
This study is among the first to compare directly
episodic memory processing among HIV+ male and
female substance users. Sophisticated functional
neuroimaging studies drawing from the addiction
and cognitive neuroscience literature will enable us
to investigate the integrity and underlying mechan-
isms of different episodic memory components
among men and women living with HIV/AIDS.
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